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Recently, peroral endoscopic myotomy (POEM) was in-
troduced as a novel therapeutic modality for the treatment of 
achalasia and spastic esophageal motility disorders. The first 
case of achalasia treated with POEM was reported in Japan in 
2008. POEM has been widely used by many skillful endosco-
pists worldwide and is rapidly becoming popular. It involves 
the application of esophageal myotomy to the concept of 
natural orifice transluminal surgery by utilizing a submucosal 
tunneling method and aims at combining the benefits of the 
endoscopic minimal invasive approach with the good long-
term efficacy of Heller myotomy. Clinical outcomes of this 
new therapeutic option have been reported to be excellent in 
terms of both efficacy and safety, although some concerns re-
garding the incidence of postoperative gastroesophageal reflux 
disease still exist. 
In this issue of Clinical Endoscopy, Masadeh et al. reported 
their experience of 125 cases of achalasia and spastic esoph-
ageal motility disorders treated with POEM at a tertiary U.S. 
center.1 This study also showed excellent clinical outcome 
(92% initial clinical success, persisted in 88% at 12 months), 
although it included initial cases in which POEM was per-
formed by two endoscopists in their learning curves. Accumu-
lating data, including this report, confirm the excellent clinical 
efficacy and safety of POEM.
However, this study showed more notable findings than 
just the excellent clinical outcome, including the significantly 
higher mucosal barrier failure (MBF) rate in patients with 
prior laparoscopic Heller myotomy (19% vs. 3%, p=0.015).1 
MBF was defined as a leak of contrast into the submucosal 
tunnel or mediastinum on postoperative esophagography. The 
authors discussed that obliteration of the submucosal space 
by fibrosis and inability to avoid the scarred area may play a 
role in this finding. Actually, previous endoscopic or surgical 
treatment may induce submucosal fibrosis at the esophago-
gastric (EG) junction, hindering safe submucosal tunneling.2 
Fundoplication accompanied by Heller myotomy may also 
result in a complex angle of the EG junction.2 However, several 
reports showed similar clinical outcomes and adverse events 
of POEM for patients with and without prior endoscopic or 
surgical therapy.3-9 These studies argue that previous endo-
scopic and even surgical treatments are not a contraindication 
for POEM,2-9 and these findings are discordant with those of 
the report by Masadeh et al. in the current issue.1 We need to 
discuss the reasons for this disagreement. 
First, in reality, many POEM endoscopists agree on the 
higher difficulty of POEM in previously heavily treated acha-
lasia patients. However, accumulated experience and skills 
enable POEM endoscopists to manage and overcome submu-
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cosal fibrosis. Therefore, there might be a smaller difference in 
the rate of adverse events on a larger scale in POEM reports. 
In this study by Masadeh et al., MBF as adverse events mostly 
occurred early in their clinical experience, so there might be 
a “learning curve” issue.1 Additionally, we must also consider 
the possibility of “publication bias” because we know that su-
perior and safer clinical outcomes are easier to be accepted for 
publication. 
Second, a recent publication showed findings concordant 
with those reported by Masadeh et al. in this issue.1 Wang et al. 
reported a large-scale clinical series of 1,912 cases treated with 
POEM, focusing on mucosal injury (MI) during POEM.10 In 
this study, the authors found that MI was independently asso-
ciated with previous Heller myotomy (odds ratio [OR], 2.094; 
p=0.026), previous POEM (OR, 2.441; p=0.033), submucosal 
fibrosis (OR, 4.530; p <0.001), mucosal edema (OR, 1.834; 
p=0.001), and tunnel length ≥13 cm (OR, 2.699; p<0.001). 
They also found that POEM experience of >1 year was a pro-
tective factor for MI (OR, 0.614; p=0.042).10 This large-scale 
study showed that previous Heller myotomy and submucosal 
fibrosis are definite risk factors for MI as an adverse event, and 
accumulated experience of POEM can play a role as a protec-
tive factor.
In case of rescue POEM after previous Heller myotomy, 
following tips should be noted to overcome the difficulties 
caused by fibrosis. First, the submucosal tunnel should be 
made at a different axis from that of the previous myotomy, to 
avoid the submucosal fibrosis and scar regions of the previous 
myotomy. Therefore, a meticulous review of previous surgical 
notes is mandatory. Because in most cases, Heller myotomy 
is performed in the anterior aspect, rescue POEM is generally 
recommended for approach in the posterior aspect of the 
esophagus. Second, if submucosal fibrosis is too broad to be 
avoided, submucosal tunneling should be performed as deep 
as possible. While damage to the muscularis propria during 
tunneling does not significantly affect the outcome, mucosal 
damage from electrocoagulation or a mucosal tear can often 
cause adverse events. Moreover, the use of cutting current 
rather than the spray coagulation mode of an electrosurgical 
unit may help reduce electrocoagulation damage to the muco-
sal layer in highly fibrotic areas. Third, rescue POEM should 
be performed by fully experienced POEM endoscopists be-
cause it is often technically demanding compared to standard 
POEM. Onimaru et al. recommended an experience of at least 
30 cases of standard POEM before attempting rescue POEM 
based on their study.2
To conclude this commentary, POEM has been rapidly 
becoming popular worldwide owing to its excellent clinical 
outcomes in a short period of time, and indications for POEM 
are expanding to include long-standing sigmoid-shaped acha-
lasia, other spastic esophageal motility disorders, and even 
previously failed endoscopic treatment or surgical myotomy 
cases. However, rescue POEM after previous Heller myotomy 
is often highly technical, so it may be better performed by a 
fully experienced POEM endoscopist. A study from the U.S. 
by Masadeh et al. also showed excellent clinical outcomes of 
POEM and gives us a chance to learn how to reduce the ad-
verse events of rescue POEM.1
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